The FDA's Drug Abuse Advisory Committee performed a formal review of the tramadol
abuse evidence in 1998, including the data from Ortho-McNeil's surveillance
studies and federal case reporting/surveillance programs. The FDA did not recommend
changing tramadol's unscheduled status. (9) The FDA's considered decision to
not schedule tramadol as a controlled substance implies its abuse risk to the
general population is low in comparison to its novel analgesic benefit.
1 - 2 - Next
Find Featured Titles for: Business & Finance
click to hide
Academy of Marketing Science Review
Accounting Historians Journal, The
Accounting History
AgExporter
Agricultural Research
Agricultural and Resource Economics Review
Air Force Comptroller
Air Safety Week
Airline Industry Information
American Demographics
American Fruit Grower
American Journal of Potato Research
Architectural Review, The
Asian Economic News
Entrepreneur
cialis - check it
tramadol - check it
viagra - check it
levitra - check it
phentermine - check it
xenical - check it
prozac - check it
zoloft - check it
fioricet - check it
paxil - check it
propecia - check it
ultram - check it